May 29: The Week in Cancer News A study shows that a more tolerable, dose-adjusted chemotherapy regimen can effectively treat a rare lymphoma, and data from registries provide information on which cancer patients are at greatest risk of death from COVID-19. by Kate Yandell May 22: The Week in Cancer News A study finds that metastatic prostate cancer incidence rose after the U.S. Preventive Services Task Force urged against routine PSA testing, and the Food and Drug Administration approves two PARP inhibitors for treatment of prostate cancer. by Kate Yandell May 15: The Week in Cancer News A study indicates that children with cancer are not at increased risks of severe cases of COVID-19, and researchers find that Medicaid expansion was associated with reduced cancer deaths. by Kate Yandell May 8: The Week in Cancer News A study finds that opioid deaths have slightly increased among people with cancer, and the Food and Drug Administration approves a targeted therapy for non-small cell lung cancer. by Kate Yandell May 1: The Week in Cancer News At the AACR Virtual Annual Meeting I, researchers presented new data on cancer biology, treatment, screening and risk reduction. by Cancer Today Staff April 24: The Week in Cancer News A third of cancer survivors report that they or their partners have stayed in jobs due to concerns about keeping health insurance, and the Food and Drug Administration approves a new treatment for metastatic triple-negative breast cancer. by Kate Yandell April 17: The Week in Cancer News A study shows that antibiotic use prior to starting immunotherapy for melanoma is associated with decreased survival, and the Food and Drug Administration approves a treatment for advanced HER2-positive breast cancer. by Kate Yandell April 10: The Week in Cancer News A study indicates that the rate of e-cigarette use is elevated in young adults with a history of cancer, and oncologists write about the impact of COVID-19. by Kate Yandell April 3: The Week in Cancer News CAR-T cell therapy shows promise for treating mantle cell lymphoma, and the Food and Drug Administration requests that drugmakers pull the anti-heartburn drug ranitidine due to concerns about a contaminant that may increase cancer risk. by Kate Yandell March 27: The Week in Cancer News Cancer patients and survivors share tips for coping with the uncertainty and isolation brought on by the coronavirus, and the coronavirus is impacting cancer clinical trials and treatment. by Kate Yandell and Marci A. Landsmann next